09/22/2022
NEW for Netherton- Quoin Pharmaceuticals, Ltd. is developing a topical medication containing a new investigational active ingredient, combined with a proprietary polymer delivery system, for the treatment of Netherton Syndrome. https://www.firstskinfoundation.org/netherton-syndrome-study-quoin